Cyclical sinus bradycardia and atrioventricular block induced by ticagrelor
Sign Up to like & getrecommendations! Published in 2018 at "HeartRhythm Case Reports"
DOI: 10.1016/j.hrcr.2018.07.017
Abstract: Ticagrelor, a direct-acting and reversible P2Y12-adenosine diphosphate receptor antagonist, is recommended as a first-line antithrombotic agent in patients with acute coronary syndromes.1 The superiority of ticagrelor over other P2Y12 antagonists is thought to be mediated… read more here.
Keywords: cyclical sinus; atrioventricular block; ticagrelor; sinus bradycardia ... See more keywords